Triumph-2 enrolled 1,152 adults with type 2 diabetes and obesity or overweight, randomized to Retatrutide 4 mg, 9 mg, 12 mg, or placebo over 80 weeks
Our guides on calorie targets on semaglutide and calorie targets on tirzepatide can help you understand your approximate maintenance needs
The Federal Trade Commission's lawsuit says New York-based telehealth company called NextMed ran a series of advertisements promoting its weight loss program in 2022 and 2023
212,213 The pathophysiological mechanism of GLP-1 in metabolic diseases GLP-1 plays a crucial role in the pathophysiology of metabolic diseases, particularly in T2DM and obesity
The SELECT trial result - 20% reduction in major cardiovascular events with weekly semaglutide 2.4mg in adults with established cardiovascular disease plus overweight/obesity - was the first time a weight-loss medication demonstrated cardiovascular outcome benefits in a major randomized controlled trial
both can offer relief during times of stomach discomfort